Evidence map›Paper›PMID 32822419›Full record

ArticlePloS one2020

Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site.

Anne Zeddeman, Evi van Schuppen, Kristianne E Kok, Marjolein van Gent, Kees J Heuvelman, Marieke J Bart, Han G J van der Heide, Joshua Gillard, Elles Simonetti, Marc J Eleveld and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. The First Reported Case ofOpen forum infectious diseases · 2022
    Article
  8. Can vaccines control bacterial virulence and pathogenicity?Evolution, medicine, and public health · 2022
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Anne ZeddemanSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Evi van SchuppenSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Kristianne E KokCentre for Infectious Diseases Research, Diagnostics and Screening (IDS), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.ORCID 0000-0003-0568-5988
Marjolein van GentCentre for Infectious Diseases Research, Diagnostics and Screening (IDS), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Kees J HeuvelmanCentre for Infectious Diseases Research, Diagnostics and Screening (IDS), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Marieke J BartCentre for Infectious Diseases Research, Diagnostics and Screening (IDS), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Han G J van der HeideCentre for Infectious Diseases Research, Diagnostics and Screening (IDS), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Joshua GillardSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0001-8509-2212
Elles SimonettiSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Marc J EleveldSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0001-7454-018X
Fred J H van OpzeelandSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Saskia van SelmSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Ronald de GrootSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0001-5266-5002
Marien I de JongeSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Frits R MooiSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0002-5779-6252
Dimitri A DiavatopoulosSection Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0001-7065-7807
Radboud University Nijmegen · NLNational Institute for Public Health and the Environment · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bordetella pertussis vaccine escape mutants that lack expression of the pertussis antigen pertactin (Prn) have emerged in vaccinated populations in the last 10-20 years. Additionally, clinical isolates lacking another acellular pertussis (aP) vaccine component, filamentous hemagglutinin (FHA), have been found sporadically. Here, we show that both whole-cell pertussis (wP) and aP vaccines induced protection in the lungs of mice, but that the wP vaccine was more effective in nasal clearance. Importantly, bacterial populations isolated from the lungs shifted to an FHA-negative phenotype due to frameshift mutations in the fhaB gene. Loss of FHA expression was strongly selected for in Prn-deficient strains in the lungs following aP but not wP vaccination. The combined loss of Prn and FHA led to complete abrogation of bacterial surface binding by aP-induced serum antibodies. This study demonstrates vaccine- and anatomical site-dependent adaptation of B. pertussis and has major implications for the design of improved pertussis vaccines.

Indexed as

AnimalsAntibodies, BacterialBacterial Outer Membrane ProteinsBordetella pertussisDiphtheria-Tetanus-acellular Pertussis VaccinesGene Expression RegulationHemagglutininsLungMiceVaccinationVirulence Factors, BordetellaWhooping CoughAntibodies, BacterialBacterial Outer Membrane ProteinsDiphtheria-Tetanus-acellular Pertussis VaccinesHemagglutininspertactinVirulence Factors, Bordetella

Identifiers

PMID32822419
PMCPMC7446907
OpenAlexW3081385286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.